Retatrutide

CAS Number: 2381089-83-2
Molecular Weight: ~4413 g/mol
Type: Multi-receptor agonist peptide (GLP-1, GIP, and glucagon receptor)

Retatrutide

Retatrutide is a next-generation investigational peptide designed as a tri-agonist at GLP-1, GIP, and glucagon receptors. It is being studied as a potential therapeutic for obesity, metabolic syndrome, and type 2 diabetes, showing superior weight-loss efficacy compared to GLP-1 agonists alone.

Research Applications

• Obesity Research: Investigating profound weight-reduction effects.
• Diabetes & Metabolic Health: Studying glucose regulation and insulin sensitivity.
• Cardiovascular Studies: Exploring lipid profile improvements and reduced risk factors.
• Energy Balance: Evaluating enhanced thermogenesis and fat metabolism.

For Research Use Only
Retatrutide is sold for research and laboratory use only. Not approved for human or veterinary use.